Publications

Article: Therapeutic Innovation & Regulatory Science

Diversity Plans and Postmarketing Studies: First Impressions of Anticipated Diversity Requirements in the United States

Article: DIA Global Forum, December 2020
Volume 12 Issue 12

Impact of COVID-19 on Clinical Trial Operation and Regulatory Interactions

White Paper

How the Latest Developments Regarding Public Access to Clinical Study Reports Affect Regulatory Writing

LinkedIn Article

The Coronavirus Disease 2019 (COVID-19) Outbreak from the Perspective of a Scientist, Epidemiologist, and Medical Writer

Article: AMWA Journal, Summer 2020

Freedom to Write: New Tools for Streamlining Document Development From Start to Finish

LinkedIn Article:

Small vs. Large Consulting Firms: Does Size Really Matter?